Table 3.
Hazard ratios for all‐cause death and rehospitalization due to heart failure
| All patients | Non‐obese patients | |||||
|---|---|---|---|---|---|---|
| Non‐WL | WL | Non‐WL | WL | |||
| All‐cause death | ||||||
| No. of patients | 503 | 70 | 403 | 49 | ||
| Person‐years of follow‐up | 957.9 | 124.0 | 768.0 | 84.2 | ||
| No. of all‐cause death | 20 | 11 | 17 | 9 | ||
| Incidence rate/1000 person‐years | 20.9 | 88.7 | 22.1 | 106.9 | ||
| HR in the crude model | 1 | 4.30 | (2.06–8.99) | 1 | 4.85 | (2.15–10.81) |
| HR in the adjusted model a | 1 | 4.07 | (1.94–8.54) | 1 | 4.35 | (1.89–9.95) |
| HR in the adjusted model b , c | 1 | 3.44 | (1.61–7.35) | 1 | 5.12 | (2.08–12.5) |
| Rehospitalization due to heart failure | ||||||
| No. of patients | 503 | 70 | 403 | 49 | ||
| Person‐years of follow‐up | 909.4 | 112.3 | 730.5 | 75.0 | ||
| No. of re‐hospitalizations due to heart failure | 69 | 15 | 51 | 12 | ||
| Incidence rate/1000 person‐years | 75.9 | 133.5 | 69.8 | 159.9 | ||
| HR in the crude model | 1 | 1.82 | (1.03–3.17) | 1 | 2.37 | (1.26–4.44) |
| HR in the adjusted model a | 1 | 1.80 | (1.02–3.15) | 1 | 2.36 | (1.24–4.45) |
| HR in the adjusted model d , e | 1 | 1.90 | (1.05–3.43) | 1 | 2.63 | (1.38–5.01) |
Abbreviations: CI, confidence interval; HR, hazard ratio; WL, weight loss.
Adjusted for age and sex.
Adjusted for age, sex, past‐heart failure hospitalization, elevated levels of brain natriuretic peptide, low albumin, use of mineralocorticoid receptor antagonists, and use of vasopressin receptor antagonists.
Adjusted for age, sex, past heart failure hospitalisation, arrhythmia as an etiology, low grip strength in non‐obese patients.
Adjusted for age, sex, infiltrative cardiomyopathies as an etiology, New York Heart Association class III‐IV, use of loop diuretics, use of oral inotropic agent, low albumin, low grip stregth, walking speed in all pateints.
Adjusted for age, sex, infiltrative cardiomyopathies as an etiology, use of oral inotropic agent, low grip strength, walking speed in non‐obese patients.